-
EP2952191
European procedure
Extract from the Register of European Patents
EP About this file: EP2952191
| EP2952191 - SUBLINGUAL APOMORPHINE [Right-click to bookmark this link] | Status | Opposition rejected Status updated on 01.12.2023 Database last updated on 31.03.2026 | |
| Former | The patent has been granted Status updated on 20.07.2018 | ||
| Former | Grant of patent is intended Status updated on 27.02.2018 | ||
| Former | Examination is in progress Status updated on 04.08.2017 | Most recent event Tooltip | 01.12.2023 | Opposition rejected | published on 03.01.2024 [2024/01] | Applicant(s) | For all designated states Sunovion Pharmaceuticals Inc. 84 Waterford Drive Marlborough, MA 01752 / US | [2018/34] |
| Former [2017/03] | For all designated states Sunovion Pharmaceuticals Inc. 84 Waterford Drive Marlborough, MA 01752 / US | ||
| Former [2015/50] | For all designated states Cynapsus Therapeutics Inc. 828 Richmond St W Toronto, ON M5J 1C9 / CA | Inventor(s) | 01 /
Giovinazzo, Anthony John 1302 Kestell Blvd. Oakville, Ontario L6H 0B9 / CA | 02 /
Hedden, David Bruce 2483 Dundee Drive Ann Arbor, MI 48103 / US | 03 /
de Somer, Marc L. 4 Upland Road Winchester, Massachusetts 01890 / US | 04 /
Bryson, Nathan John 99 Glen Rd., Apt. 1 Toronto, Ontario M4W 2V8 / CA | [2018/34] |
| Former [2016/22] | 01 /
Giovinazzo, Anthony John 1302 Kestell Blvd. Oakville, Ontario L6H 0B9 / CA | ||
| 02 /
Hedden, David Bruce 2483 Dundee Drive Ann Arbor, MI Michigan 48103 / US | |||
| 03 /
de Somer, Marc L. 4 Upland Road Winchester, Massachusetts 01890 / US | |||
| 04 /
Bryson, Nathan John 99 Glen Rd., Apt. 1 Toronto, Ontario M4W 2V8 / CA | |||
| Former [2015/50] | 01 /
Giovinazzo, Anthony John 1302 Kestell Blvd. Oakville, Ontario L6H 0B9 / CA | ||
| 02 /
Hedden, David Bruce 2483 Dundee Drive Ann Arbor, MI Michigan 48103 / US | |||
| 03 /
de Somer, Marc L. 12360 Main Campus Drive Lexington, MA Massachusetts 02421 / US | |||
| 04 /
Bryson, Nathan John 99 Glen Rd., Apt. 1 Toronto, Ontario M4W 2V8 / CA | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | [2018/34] |
| Former [2015/50] | Høiberg A/S St. Kongensgade 59 A 1264 Copenhagen K / DK | Application number, filing date | 15175258.1 | 11.06.2010 | [2015/50] | Priority number, date | US20090186445P | 12.06.2009 Original published format: US 186445 P | [2015/50] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2952191 | Date: | 09.12.2015 | Language: | EN | [2015/50] | Type: | B1 Patent specification | No.: | EP2952191 | Date: | 22.08.2018 | Language: | EN | [2018/34] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 19.10.2015 | Classification | IPC: | A61K31/473, A61K31/44, A01N43/42, A61K47/02, A61P15/10, A61P25/16 | [2015/50] | CPC: |
A61K31/485 (EP,BR,IL,US);
A61K9/0056 (EP,BR,IL,US);
A61K9/70 (IL,KR);
A61K31/44 (IL,KR);
A61K31/473 (EP,IL,US);
A61K47/02 (EP,BR,IL,US);
A61K47/10 (IL,US);
A61K47/18 (BR,IL);
A61K9/006 (EP,BR,IL,US);
A61K9/06 (EP,IL,US);
A61K9/2086 (EP,IL,US);
A61K9/7007 (EP,IL,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2016/29] |
| Former [2015/50] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR | Extension states | BA | 09.06.2016 | Title | German: | SUBLINGUALES APOMORPHIN | [2015/50] | English: | SUBLINGUAL APOMORPHINE | [2015/50] | French: | APOMORPHINE SUBLINGUALE | [2015/50] | Examination procedure | 09.06.2016 | Amendment by applicant (claims and/or description) | 09.06.2016 | Examination requested [2016/29] | 07.08.2017 | Despatch of a communication from the examining division (Time limit: M03) | 16.11.2017 | Reply to a communication from the examining division | 28.02.2018 | Communication of intention to grant the patent | 10.07.2018 | Fee for grant paid | 10.07.2018 | Fee for publishing/printing paid | 10.07.2018 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP10786915.8 / EP2442650 | Divisional application(s) | EP18189805.7 / EP3434270 | Opposition(s) | Opponent(s) | 01
22.05.2019
ADMISSIBLE D Young & Co LLP 120 Holborn London EC1N 2DY / GB Opponent's representative D Young & Co LLP 3 Noble Street London EC2V 7BQ / GB | [N/P] |
| Former [2019/26] | |||
| Opponent(s) | 01
22.05.2019
ADMISSIBLE D Young & Co LLP 120 Holborn London EC1N 2DY / GB Opponent's representative D Young & Co LLP 120 Holborn London EC1N 2DY / GB | 05.06.2019 | Invitation to proprietor to file observations on the notice of opposition | 15.10.2019 | Reply of patent proprietor to notice(s) of opposition | 03.08.2020 | Cancellation of oral proceeding that was planned for 15.09.2020 | 15.09.2020 | Date of oral proceedings | 24.06.2021 | Date of oral proceedings | 04.08.2021 | Despatch of minutes of oral proceedings | 04.08.2021 | Date of despatch of rejection of opposition | 23.11.2023 | Legal effect of rejection of opposition [2024/01] | Appeal following opposition | 04.10.2021 | Appeal received No. T1868/21 | 04.10.2021 | Payment of appeal fee | 13.12.2021 | Statement of grounds filed | 23.11.2023 | Result of appeal procedure: appeal of the opponent withdrawn | Fees paid | Renewal fee | 03.11.2015 | Renewal fee patent year 03 | 03.11.2015 | Renewal fee patent year 04 | 03.11.2015 | Renewal fee patent year 05 | 03.11.2015 | Renewal fee patent year 06 | 27.06.2016 | Renewal fee patent year 07 | 27.06.2017 | Renewal fee patent year 08 | 27.06.2018 | Renewal fee patent year 09 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 22.08.2018 | CY | 22.08.2018 | HR | 22.08.2018 | LT | 22.08.2018 | LV | 22.08.2018 | MK | 22.08.2018 | MT | 22.08.2018 | SI | 22.08.2018 | SK | 22.08.2018 | SM | 22.08.2018 | BG | 22.11.2018 | [2022/31] |
| Former [2021/34] | AL | 22.08.2018 | |
| CY | 22.08.2018 | ||
| HR | 22.08.2018 | ||
| LT | 22.08.2018 | ||
| LV | 22.08.2018 | ||
| MT | 22.08.2018 | ||
| SI | 22.08.2018 | ||
| SK | 22.08.2018 | ||
| SM | 22.08.2018 | ||
| BG | 22.11.2018 | ||
| Former [2021/26] | AL | 22.08.2018 | |
| CY | 22.08.2018 | ||
| HR | 22.08.2018 | ||
| LT | 22.08.2018 | ||
| LV | 22.08.2018 | ||
| SI | 22.08.2018 | ||
| SK | 22.08.2018 | ||
| SM | 22.08.2018 | ||
| BG | 22.11.2018 | ||
| Former [2019/37] | AL | 22.08.2018 | |
| HR | 22.08.2018 | ||
| LT | 22.08.2018 | ||
| LV | 22.08.2018 | ||
| SI | 22.08.2018 | ||
| SK | 22.08.2018 | ||
| SM | 22.08.2018 | ||
| BG | 22.11.2018 | ||
| Former [2019/27] | AL | 22.08.2018 | |
| HR | 22.08.2018 | ||
| LT | 22.08.2018 | ||
| LV | 22.08.2018 | ||
| SK | 22.08.2018 | ||
| SM | 22.08.2018 | ||
| BG | 22.11.2018 | ||
| Former [2019/24] | AL | 22.08.2018 | |
| HR | 22.08.2018 | ||
| LT | 22.08.2018 | ||
| LV | 22.08.2018 | ||
| SK | 22.08.2018 | ||
| BG | 22.11.2018 | ||
| Former [2019/12] | AL | 22.08.2018 | |
| HR | 22.08.2018 | ||
| LT | 22.08.2018 | ||
| LV | 22.08.2018 | ||
| BG | 22.11.2018 | ||
| Former [2019/07] | LT | 22.08.2018 | Documents cited: | Search | [Y] WO9848781 (PENTECH PHARMACEUTICALS INC et al.) | [Y] WO2006120412 (AMARIN PHARMACEUTICALS IRELAND et al.) | [Y] WO9826763 (LOHMANN THERAPIE SYST LTS et al.) | [Y] WO2007075422 (MONOSOIRX LLC et al.) | [Y] WO9325168 (THERATECH INC et al.) | [Y] US6566368 (EL-RASHIDY RAGAB et al.) | [Y] US2005031677 (PATHER S INDIRAN et al.) | by applicant | WO03080074 | US4687773 | WO2005099702 | WO2009052421 | US2006210610 | US2001006677 | US4746508 | US4540602 | US5145684 | US5518187 | US5718388 | US5862999 | US5665331 | US5662883 | US5560932 | US5543133 | US5534270 | US5510118 | US5470583 | US6976647 | EP0498482 | VAN LAAR T., CNS DRUGS, vol. 17, 2003, pages 475 | DEWEY RB JR., NEUROLOGY, vol. 62, no. 4, 2004, pages S3 - S7 | SWOPE DM., NEUROLOGY, vol. 62, no. 4, 2004, pages S27 - S31 | DEFFOND ET AL., J. NEUROL. NEUROSURG. PSYCHIATRY, vol. 56, 1993, pages 101 | KOLLER ET AL., NEUROLOGY, vol. 62, 2004, pages 22 | PRIETZ ET AL., J. NEUROL. NEUROSURG. PSYCHIATRY, vol. 65, 1998, pages 709 | BORGMAN ET AL., J. MED. CHEM., vol. 19, 1976, pages 717 | ATKINSON ET AL., J. PHARMA. SCI., vol. 65, 1976, pages 1685 | CAMPBELL ET AL., NEUROPHARMACOLOGY, vol. 21, 1982, pages 953 | Opposition | WO9706786 | WO2006120412 | US2005031677 | CA2274893 | ONDO W ET AL.: "A novel sublingual apomorphine treatment for patients with fluctuating Parkinson's disease", MOVEMENT DISORDERS, vol. 14, no. 4, July 1999 (1999-07-01), pages 664 - 668, XP055292250 DOI: http://dx.doi.org/10.1002/1531-8257(199907)14:4<664::AID-MDS1017>3.0.CO;2-5 | WEINBERG ET AL.: "Sublingual absorption of selected opioid analgesics", CLIN PHARMACOL THER, vol. 44, no. 3, September 1988 (1988-09-01), pages 335 - 342, XP001058150 |